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Introduction
!
A number of studies have investigated the utility
of diagnostic systems for gastric epithelial neo-
plasms based on the identification of subepithe-
lial microvascular architecture and microsurface
architecture through magnifying observation.
The validity and legitimacy of these reports are
widely acknowledged [1–10]. Through the exam-
ination of gastric epithelial neoplasia and precan-
cerous intestinal metaplasia with magnifying
endoscopy, the authors detected the presence of
a white substance that is not permeable to light,
which we called “white opaque substance”
(WOS) in our earlier report [10]. We found that
the morphologic characteristics of the WOS can
be used to distinguish between cancerous and
noncancerous lesions [11]. More recently, we
demonstrated that the WOS is an accumulation
of tiny lipid droplets in the epithelium [12,13].
However, we do not yet know the origin or source
of the lipid droplets.
In this study, we administered an oral lipid prep-
aration to patients with gastric epithelial neopla-
sia and determined endoscopically whether this
was associated with an increase in lipid droplets
in the epithelial neoplasms.
Materials and methods
!
Study design and participants
The study was a single-center, nonrandomized,
unblinded, prospective intervention study, per-
formed in accordance with the provisions of the
Helsinki Declaration. The study design was ap-
proved by the University of Fukuoka Clinical Trials
Review Board. All participating patients were
supplied with an explanation of the study and
provided written consent.
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Background and study aims: The authors have
successfully demonstrated that the white opaque
substance (WOS) identified in gastric epithelial
neoplasms is an accumulation of minute lipid
droplets on the epithelial neoplasm. It is not
known whether the lipid droplets originate from
externally ingested lipids (typically foods). The
purpose of this study was to investigate whether
the oral ingestion of foods containing emulsified
fats increases the density of the WOS in epithelial
neoplasms.
Patients and methods: We examined 92 gastric
epithelial neoplastic lesions in 89 patients. The
patients were given emulsified fatty foods before
the procedure, and magnifying endoscopy with
narrow-band imaging (M-NBI) was used to image
the lesions. An increase in WOS density after the
ingestion of emulsified fatty foods was defined as
a positive fat-loading test result.
The patients were divided into the following
groups: control group, no emulsified fat adminis-
tered; group 1, fatty food administered 16 hours
prior; group 3, fatty food administered both 16
and 4 hours prior. The proportion of positive
fat-loading test results was determined in all
groups.
Results: The rates of positive fat-loading test re-
sults were as follows: control group, 9%; group
1, 26%; group 2, 52%; group 3, 78%. The increase
in the rates of positive fat-loading test results in
groups 2 and 3 relative to the rate in the control
group was statistically significant (chi-squared
test).
Conclusions: This study demonstrated for the
first time that the ingestion of external lipids
causes lipid droplets to aggregate in situ on the
gastric epithelial neoplasm. These results can be
used to develop a novel functional endoscopy
technique that harnesses the lipid absorption ca-
pacity of neoplasms.
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We enrolled consecutive patients with gastric epithelial neopla-
sia (adenoma or early gastric cancer) who underwent endoscopic
mucosal resection (EMR) or endoscopic submucosal dissection
(ESD) at Fukuoka University Chikushi Hospital between January
2011 and November 2012, and who satisfied the following inclu-
sion criteria:
▶ Magnifying endoscopy with narrow-band imaging (M-NBI)
before ESD of the gastric epithelial neoplasm yielded at least
three in-focus images on the oral side of the target lesion.
▶ The patient had an Eastern Cooperative Oncology Group
(ECOG) performance status of either 0 or 1 [14].
▶ The patient was 20 years of age or older at the time of regis-
tration.
▶ The patient was capable of ingesting the test meal.
▶ The patient had provided written consent to participate in the
study.
Patients were excluded from the study based on the following
criteria: lesions with associated inflammation, ulceration, or he-
morrhage that restricted observation of the lesion surface; his-
tory of gastrectomy; serious concomitant disease or illness; lac-
tose intolerance.
Histopathologic diagnosis
Histopathologic diagnosis of the lesions targeted in the fat-load-
ing test was made through the examination of ESD specimens,
based on the Vienna classification system [15,16]:
▶ C1, negative for neoplasia
▶ C2, indefinite for neoplasia
▶ C3, mucosal low grade neoplasia (low grade dysplasia/adeno-
ma)
▶ C4, mucosal high grade neoplasia
▶ C4.1, high grade dysplasia/adenoma
▶ C4.2, noninvasive carcinoma (carcinoma in situ)
▶ C4.3, intramucosal carcinoma
▶ C5, submucosal invasion by tumor
C3 lesions were classified as low grade adenomas. C4 and C5 le-
sions were classified as early gastric cancers and further sub-
divided into differentiated and undifferentiated types.
Endoscopy system and endoscopy procedures
We used Evis Lucera Spectrum, an electronic NBI endoscopy sys-
tem (Olympus, Tokyo, Japan) that features the GIF-Q240Z upper
gastrointestinal tract endoscope with optical magnification
(Olympus) and has a maximum resolution of 7.9µm [2]. A soft
black hood attachment (MAJ-1989, Olympus [4]) was fitted to
the tip of the endoscope during examination. Structural en-
hancement was set to level B8 for NBI observation, and NBI color
mode 1 was used. The examination technique was as reported
previously [4].
For the purpose of this study, we examined the oral end of the le-
sion. After initial examination with conventional white-light
imaging, we examined the lesion with M-NBI and took photo-
graphs of three different sites at maximum magnification. Still
images were stored in the Solemio ENDO version 3.3 image re-
cording system (Olympus). Endoscopic examinations were per-
formed by specialists accredited by the Japan Gastroenterological
Endoscopy Society or with similar qualifications.
Administration of emulsified fatty food
The patients were given ice cream, which contains both fats and
emulsifiers. We used Sou brand (Lotte Co., Ltd., Tokyo, Japan),
which had a fat content of 12% and 241kcal per 190-mL serving.
The subjects were divided into four groups as follows: control
group, emulsified fatty food not administered; group 1, adminis-
tration of 1 cup of emulsified fatty food 16 hours before endos-
copy; group 2, administration of 1 cup of emulsified fatty food 4
hours before endoscopy; group 3, administration of 1 cup of
emulsified fatty food 16 hours before endoscopy, followed by an-
other 1 cup 4 hours before the procedure.
Two examinations were performed in this study. Patients with a
diagnosis of gastric epithelial neoplasia (adenoma or cancer) un-
derwent the initial endoscopic examination as an outpatient pro-
cedure. The second endoscopic examinationwas performed as an
inpatient procedure after the patient had provided consent and
been formally registered in the study. The patients then con-
sumed the emulsified fatty food at the time assigned before the
second examination. The second M-NBI examination was per-
formed before ESD; as with the initial examination, images were
stored for three sites on the oral side of the lesion.
Patients in the control group were not administered emulsified
fatty food before the second examination. Patients in group 1
were administered 1 cup of emulsified fatty food 16 hours prior,
patients in group 2 were administered 1 cup of emulsified fatty
food 4 hours prior, and patients in group 3 were administered 1
cup of emulsified fatty food 16 hours prior, followed by a second
cup 4 hours prior, for a total of 2 cups.
Fat-loading test analysis
The fat-loading test results were analyzed by two endoscopists
who were experienced in gastric magnifying endoscopy and had
at least three years’ experience in M-NBI. The endoscopists had
not been involved in the examination procedure in any way and
were given no patient information. They assessed images ran-
domly chosen from the first and second examinations. When
their assessments of a particular image differed, the two endos-
copists were asked to review the image and to make a decision
after discussion.
The fat-loading test result (positive or negative) was determined
by using the followingWOS density ratings (●" Fig.1): grade 0, no
evidence of WOSwithin the lesion; grade 1, WOS observed in up
to one-third of the lesion; grade 2, WOS observed in more than
one-third but up to two-thirds of the lesion; grade 3, WOS ob-
served in more than two-thirds of the lesion.
A result of the fat-loading test was positive when the WOS grade
in the second endoscopic imagewas at least one level higher than
the grade in the initial image; otherwise the result was negative.
Primary end point
The primary end point for this study was evidence of differences
between groups in the fat-loading test results.
Statistical analysis
Statistical analysis was performed with SPSS software version
11.5 J for Windows (SPSS Inc., Chicago, Illinois, USA). The chi-
squared test, Fisher’s exact test, and one-way analysis of variance
(ANOVA) were used for differences between groups in the rates of
positive fat-loading test results. Differences between the average
values for each group were considered statistically significant if
the P value was less than 0.05.
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Results
!
This study involved the examination of 92 lesions from January
2011 to November 2012.The lesions were divided into four
groups of 23 each: a control group and groups 1, 2, and 3. Consent
for participation was obtained from all patients. There were no
withdrawals from the study.
●" Table1 and●" Table2 show the demographic and clinical char-
acteristics of the patients and lesions. No statistically significant
differences were identified between groups with respect to aver-
age age, gender, lesion diameter, macroscopic type, or lesion site.
●" Table3 shows the histopathologic findings. Again, there were
no statistically significant differences between groups with re-
spect to the histopathologic findings.
The rates of positive fat-loading test results for each group were
as follows (●" Fig.2): control group, 9% (2/23) [95%CI 0–20.2%];
group 1, 26% (6/23) [95%CI 10.7–41.5%]; group 2, 48% (11/23)
[95%CI 27.4–68.2%]; group 3, 78% (18/23) [95%CI 61.4–95.1%].
Positive results were significantly more likely in group 3 than in
the control group (P<0.001;●" Fig.3). In addition, the positive re-
sult rate was significantly higher in group 2 than in the control
group (P =0.022).
Fig.1 White opaque substance (WOS) grading
scale. WOS density is classified as follows (arrows
indicate the demarcation line for gastric epithelial
neoplasms): grade 0, no evidence of WOS within
the neoplasm; grade 1, WOS observed in up to one-
third of the neoplasm; grade 2, WOS observed in
more than one-third but in up to two-thirds of the
neoplasm; grade 3, WOS observed in more than
two-thirds of the neoplasm.
Table 1 Demographic character-
istics of the patients in the ana-
lyzed groups.
Control group (n=23) Group 1 (n=22) Group 2 (n=21) Group 3 (n=23)
Mean age (range), y 67.7 (51–83) 76.3 (61–87) 71.8 (36–87) 70.1 (58–83)
Male-to-female ratio 18:5 14:8 16:5 15:8
Table 2 Characteristics of the
lesions in the analyzed groups.
Control group (n=23) Group 1 (n=23) Group 2 (n=23) Group 3 (n=23)
Mean size of tumor (range), mm 16.3
(2–40)
13.1
(3–25)
15.2
(3–30)
19.4
(3–42)
Morphologic type, n (%)1
0-I
0-IIa
0-IIb
0-IIc
1 (4)
5 (22)
4 (17)
13 (57)
3 (13)
8 (35)
1 (4)
11 (48)
1 (4)
7 (31)
1 (4)
14 (61)
2 (8)
8 (35)
0 (0)
13 (57)
Tumor location, n (%)
U
M
L
6 (26)
8 (35)
9 (39)
5 (22)
9 (39)
9 (39)
6 (26)
8 (35)
9 (39)
4 (17)
7 (31)
12 (52)
U, upper; M, middle; L, lower part of the stomach.
1 Paris classification.
Table 3 Histopathologic characteristics of lesions in the analyzed groups.
Histologic type Control group (n=23) Group 1 (n=23) Group 2 (n=23) Group 3 (n=23)
Low grade adenoma, n (%) 3 (13) 6 (26) 4 (17) 7 (30)
Adenocarcinoma of differentiated type, n (%) 19 (83) 16 (70) 16 (70) 15 (66)
Adenocarcinoma of undifferentiated type, n (%) 1 (4) 1 (4) 3 (13) 1 (4)
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Discussion
!
The rates of positive results of the fat-loading test in group 2 (ad-
ministered an emulsified fatty food 4 hours before examination)
and group 3 (administered an emulsified fatty food 16 and 4
hours before examination) were significantly higher than the
corresponding rates in the control group (patients not given the
emulsified fatty food). We therefore concluded that the external
administration of lipids caused a significant increase in WOS
density in the gastric epithelial neoplasms. However, there was
no statistically significant difference between the results for
group 1 (emulsified fatty food administered 16 hours before ex-
amination) and the control group, indicating that WOS density
rises relatively quickly after ingestion (i. e., within 4 hours).
This study has shown that the external ingestion of lipids in-
creases WOS density (i. e., the density of lipid droplets), suggest-
ing that lipids are absorbed by gastric epithelial neoplasms. Rubin
et al. reported that orally administered lipids (in the form of a li-
quid containing emulsified fats) were absorbed by the gastric
mucosa associated with intestinal metaplasia [17]. To the best of
our knowledge, however, ours is the first study to demonstrate
conclusively that external lipids are absorbed by gastric epithelial
neoplasms (cancer or adenoma) via the lumen.
The normal process for digestion and absorption of lipids is as fol-
lows: Orally ingested lipids are combinedwith lingual and gastric
lipase in the stomach, where hydrolysis converts approximately
10% of triglycerides into glycerol and free fatty acids. Lipids pas-
sing through to the small intestine are emulsified by bile salts
and lipid breakdown products, then dispersed through the aqu-
eous solution in the form of minute lipid droplets. The digestion
of lipid droplets is aided by pancreatic lipase, cholesterol ester-
ase, phospholipase A2, and colipase. The end products of lipid di-
gestion –monoglycerides, fatty acids, cholesterol, lysophospholi-
pids, and free fatty acids – are solubilized within micelles, which
are then dispersed to the brush borders of small-intestinal epi-
thelial cells. The micelles are needed to pass through the brush
border nondispersion layer. The lipids are released from the mi-
celles at the lumen membrane and are dispersed through the cell
in accordance with the concentration gradient [18–20].
Accordingly, lipid absorption requires the creation of emulsified
micelles. The authors believe that the oral ingestion of emulsified
fatty food is an effective way to promote lipid absorption in gas-
tric epithelial neoplasms. We assumed that the absorption of
emulsified fats in the stomach in this study might be due to the
presence of lingual and gastric lipase, as well as pancreatic lipase
and bile acids passing from the duodenum into the stomach. It
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Fig.2 Positive results in the fat-loading test. Control group, no emulsified
lipid food loading; group 1, administration of 1 cup 16 hours before endo-
scopic examination; group 2, administration of 1 cup 4 hours before
endoscopic examination; group 3, administration of 1 cup 16 hours before
and 1 cup 4 hours before endoscopic examination (i. e., 2 loadings).
Fig.3 Results of magnifying endoscopy with nar-
row-band imaging (M-NBI) before and after the fat-
loading test. An image from the first endoscopic
examination is shown at the upper left, and an
image from the second endoscopic examination is
shown at the upper right. The microvascular archi-
tecture is traced with yellow lines at the bottom left,
and the white opaque substance (WOS) is traced
with white lines at the bottom right. It is obvious
that the WOS density is increased after fat loading,
obscuring the blood vessels.
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may also be that neoplastic change itself enables lipid absorption
by the gastric epithelium [9]. This suggests the potential for de-
veloping a new technique to detect neoplasia based on the ad-
ministration of food or formulations that are quickly absorbed
by lesions, making them easier to identify. Such a technique
could improve our ability to diagnose cancers accurately.
In this study, the sample size was not calculated because the
study was a pilot study. The reason for this is that it was neces-
sary to determine the sample size needed for a randomized, dou-
ble-blinded trial, which is planned next. Specifically, this was a
study to determine the optimal duration of the administration
of fatty food and the number of patients needed. Limitations of
this study are that it was not a blinded trial and did not have a
randomized design, and that the number of patients needed
based on the sample size was not calculated. Moreover, WOS is
visible with both white-light imaging and NBI, but observation
with optical magnification is needed [21]. Consequently, to ob-
tain the present findings, an institution must currently have
available the equipment for optical magnification endoscopy.
These limitations will be addressed in a follow-up randomized
double-blinded study (UMIN000010516), which is currently un-
der way.
In conclusion, the authors have achieved a world first in showing
that the oral ingestion of external lipids promotes the accumula-
tion of intraepithelial lipid droplets in gastric epithelial neo-
plasms. The findings of this study can be used to develop a novel
functional endoscopy technique based on the lipid absorption ca-
pacity of gastric tumors.
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